Introduction
Intraoperative optical coherence tomography (iOCT) is a recent innovation that has been introduced as a surgical instrument for clinical procedures in the cornea and vitreous [1] [2] [3] [4] [5] [6] [7] [8] . There are two types of iOCT currently available for this purpose: a small, handheld system [2, 3] and a microscope-integrated system [4] [5] [6] [7] [8] . A recent report has shown that microscope-integrated iOCT is an effective surgical instrument and allows surgeons to visualize the surgical site in real time without the need to interrupt the procedure [9] . Another report has shown that 27-gauge microincision vitrectomy surgery (MIVS) [10] , with its very fine-shafted instruments, can reduce the invasiveness of vitreous surgery. However, there has been no report on the effectiveness of combining these systems. Furthermore, neither the usefulness of the iOCT system itself nor its compatibility with the current best techniques for vitreous surgery have been definitively established. Thus, this is the first report on iOCT-assisted 27-gauge MIVS in eyes with vitreoretinal disease.
Methods
This was a retrospective, interventional case series performed at a single center. Six eyes of 6 patients were selected from patients with retinal disease who underwent 27-gauge MIVS (Alcon Laboratories; Fort Worth, Tex., USA) with iOCT. We performed intraoperative imaging of the vitreous and retina with the RESCAN 700 (Carl Zeiss Meditec AG, Jena, Germany), a microscope-integrated iOCT system. The RESIGHT (Carl Zeiss Meditec) lens system or a vitrectomy contact lens (HHV Dispo, Type 1d, HOYA, Tokyo, Japan) were used for surgical and iOCT visualization. To determine the precise status of the macula, iOCT scanning was used to visualize the macula in real time before, during and after treatment. The surgeon (H.K.) selected the scan location with a foot pedal control, while an assistant simultaneously input the scan length and angle with a video monitor display system, following the surgeon's instructions. All patients were followed for more than 3 months after surgery. After resecting the vitreal core, 4 mg of triamcinolone acetonide (TA; MaQaid, Wakamoto Pharmaceutical Co., Ltd., Tokyo, Japan) was injected into the vitreous cavity to determine if a posterior vitreous detachment was present. If it was not present, we created one with a 27-gauge cutter. After shaving the peripheral gel, we removed the epiretinal membrane (ERM) or internal limiting membrane (ILM), removed any subretinal fluid, performed fluid-air exchange, or transplanted an ILM graft from another region, if needed. In all patients, we only used iOCT when we determined that it was in the best interests of the patient. The exact surgical procedures used varied according to the type of vitreoretinal disease.
Results
The preoperative and intraoperative demographics and postoperative courses of the 6 patients are shown in table 1. Imaging with iOCT was used to evaluate macular status in suspected cases of macular edema (case No. 1), vitreomacular traction (case No. graft. We also found that the sparing use of injected TA usefully enhanced the contrast of the images. No patient experienced any adverse events.
Discussion
The advantages of iOCT in vitreous surgery were most notable when it was used to evaluate different areas of the macula: the pre-macula, in vitreomacular traction or ERM; the intra-macula, in macular edema or macular hole; and the sub-macula, in macular detachment. The expert use of iOCT should allow surgeons to avoid performing unnecessary procedures, particularly the removal of the ILM or fluid-air exchange, and lead to minimally invasive, optimal interventions. Furthermore, to ensure that real-time iOCT imaging during macular surgery is as clear as possible, it is important that the metallic surgical instrumentation should be as fine as possible, in order to limit shadowing on the underlying tissues and allow visualization of the instrument-tissue interaction. In our experience, using iOCT with a 25-gauge system causes shadowing on the underlying tissues that is relatively greater than the shadowing caused by 27-gauge instruments. For this reason, we believe that 27-gauge MIVS, which uses the smallest currently available shafts, is the most suitable for vitrectomy with iOCT. The combination of 27-gauge MIVS and iOCT is a technically feasible and safe technique for use in eyes with vitreoretinal disease. We do not consider that there are any particular devices or techniques that can enhance iOCT imaging during surgery, other than the sparing use of TA and the skill of the surgeon in using the foot pedal accurately. It is important that TA is used only sparingly in iOCT, as dense TA or large TA clots can cause unfavorable shadowing on the underlying tissues.
Our study was somewhat limited by a small sample size and by the current limitations of the iOCT device itself, which has a display resolution lower than other currently used OCT devices and depends on the accuracy of the surgeon's skill in using the foot pedal. However, this system allowed real-time imaging and provided positive feedback that allowed the surgeon to better judge the necessity of additional surgical procedures, while causing minimal obstruction to the surgeon and enabling excellent intraoperative visualization of retinal tissues. 
